本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Addex Therapeutics Ltd

3.26
-0.2200-6.32%
盤後3.260.00000.00%18:37 EDT
成交量:2.42萬
成交額:8.01萬
市值:571.29萬
市盈率:-0.35
高:3.42
開:3.34
低:3.10
收:3.48
52周最高:11.97
52周最低:3.10
股本:175.24萬
流通股本:156.70萬
量比:0.70
換手率:1.54%
股息:- -
股息率:- -
每股收益(TTM):-9.2717
每股收益(LYR):-9.4830
淨資產收益率:-122.28%
總資產收益率:-23.59%
市淨率:1.42
市盈率(LYR):-0.34

資料載入中...

2021/09/08

超過5%披露

Addex Therapeutics Ltd.
2021/04/12

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/08

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/11

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/22

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/01/06

SEC問詢函

CORRESP [Cover] - Correspondence
2021/01/06

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/01/05

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/14

招股説明書

F-1 - Registration statement for certain foreign private issuers
2020/11/03

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/04/27

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

SEC問詢函

[Cover]Correspondence
2020/01/23

SEC問詢函

[Cover]Correspondence
2020/01/23

[修訂]招股説明書

[Amend] Registration statement for certain foreign private issuers